Yi KY - Search Results

1

A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.

Lee JH, Park BK, Oh KS, Yi KY, Lim CJ, Seo HW, Lee BH. Lee JH, et al. Among authors: yi ky. Int Immunopharmacol. 2016 Nov;40:196-202. doi: 10.1016/j.intimp.2016.09.002. Epub 2016 Sep 6. Int Immunopharmacol. 2016. PMID: 27611861

2

Synthesis and SAR of thieno[3,2-b]pyridinyl urea derivatives as urotensin-II receptor antagonists.

Lim CJ, Oh SA, Lee BH, Oh KS, Yi KY. Lim CJ, et al. Among authors: yi ky. Bioorg Med Chem Lett. 2014 Dec 15;24(24):5832-5835. doi: 10.1016/j.bmcl.2014.09.089. Epub 2014 Oct 28. Bioorg Med Chem Lett. 2014. PMID: 25452001

3

Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists.

Lim CJ, Woo SE, Ko SI, Lee BH, Oh KS, Yi KY. Lim CJ, et al. Among authors: yi ky. Bioorg Med Chem Lett. 2016 Oct 1;26(19):4684-4686. doi: 10.1016/j.bmcl.2016.08.049. Epub 2016 Aug 26. Bioorg Med Chem Lett. 2016. PMID: 27597245

4

A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.

Oh KS, Lee JH, Yi KY, Lim CJ, Park BK, Seo HW, Lee BH. Oh KS, et al. Among authors: yi ky. Eur J Pharmacol. 2017 Mar 15;799:94-102. doi: 10.1016/j.ejphar.2017.02.003. Epub 2017 Feb 3. Eur J Pharmacol. 2017. PMID: 28163023

5

A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway.

Kim MY, Ilyosbek S, Lee BH, Yi KY, Jung YS. Kim MY, et al. Among authors: yi ky. Eur J Pharmacol. 2017 May 15;803:174-178. doi: 10.1016/j.ejphar.2017.03.056. Epub 2017 Mar 28. Eur J Pharmacol. 2017. PMID: 28363746

6

The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy.

Oh KS, Lee JH, Yi KY, Lim CJ, Lee S, Park CH, Seo HW, Lee BH. Oh KS, et al. Among authors: yi ky. Br J Pharmacol. 2015 May;172(10):2618-33. doi: 10.1111/bph.13082. Epub 2015 Mar 26. Br J Pharmacol. 2015. PMID: 25597918 Free PMC article.

7

Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on ischemia and reperfusion-induced myocardial infarction in rats and dogs.

Oh KS, Seo HW, Yi KY, Lee S, Yoo SE, Lee BH. Oh KS, et al. Among authors: yi ky. Fundam Clin Pharmacol. 2007 Jun;21(3):255-63. doi: 10.1111/j.1472-8206.2007.00491.x. Fundam Clin Pharmacol. 2007. PMID: 17521294

8

A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.

Oh KS, Lee S, Yi KY, Seo HW, Koo HN, Lee BH. Oh KS, et al. Among authors: yi ky. J Pharmacol Exp Ther. 2009 Jan;328(1):10-8. doi: 10.1124/jpet.108.143719. Epub 2008 Oct 3. J Pharmacol Exp Ther. 2009. PMID: 18836068

9

4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).

Lim CJ, Kim SH, Lee BH, Oh KS, Yi KY. Lim CJ, et al. Among authors: yi ky. Bioorg Med Chem Lett. 2012 Jan 1;22(1):427-30. doi: 10.1016/j.bmcl.2011.10.111. Epub 2011 Nov 10. Bioorg Med Chem Lett. 2012. PMID: 22137790

10

Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists.

Lim CJ, Kim JY, Lee BH, Oh KS, Yi KY. Lim CJ, et al. Among authors: yi ky. Bioorg Med Chem Lett. 2013 Mar 15;23(6):1736-9. doi: 10.1016/j.bmcl.2013.01.053. Epub 2013 Jan 24. Bioorg Med Chem Lett. 2013. PMID: 23411080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters